Share this on:
 E-mail
14
VIEWS
0
COMMENTS
 
SHARES
About this iReport
  • Not vetted for CNN

  • Click to view mariarobert's profile
    Posted April 22, 2014 by
    mariarobert
    Location
    Texas, Texas

    Psoriasis (Skin Condition) Market : Reviews of Drug Profiles, Products & Projects

     


    Psoriasis - Pipeline Review, H1 2014
    Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Psoriasis - Pipeline Review in subject line and your contact details.
    Psoriasis Market Pipeline Review, H1 2014, provides an overview of the Psoriasis’s therapeutic pipeline.
    This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Psoriasis and special features on late-stage and discontinued projects
    The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
    Complete report is spread across 487 pages and available @ http://www.reportsnreports.com/reports/279987-psoriasis-pipeline-review-h1-2014.html.
    The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
    Scope

    - The report provides a snapshot of the global therapeutic landscape of Psoriasis
    - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities



    - The report reviews key players involved in the therapeutics development for Psoriasis and enlists all their major and minor projects
    - The report summarizes all the dormant and discontinued pipeline projects
    - A review of the Psoriasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
    - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
    - A detailed assessment of monotherapy and combination therapy pipeline projects
    - Coverage of the Psoriasis pipeline on the basis of target, MoA, route of administration and molecule type
    - Latest news and deals relating related to pipeline products

    Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=279987.
    Reasons to buy

    - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
    - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
    - Develop strategic initiatives by understanding the focus areas of leading companies
    - Identify and understand important and diverse types of therapeutics under development for Psoriasis
    - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
    - Devise corrective measures for pipeline projects by understanding Psoriasis pipeline depth and focus of Indication therapeutics
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
    - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
    List of Tables
    Number of Products under Development for Psoriasis, H1 2014 28
    Number of Products under Development for Psoriasis - Comparative Analysis, H1 2014 29
    Number of Products under Development by Companies, H1 2014 31
    Number of Products under Development by Companies, H1 2014 (Contd..1) 32
    Number of Products under Development by Companies, H1 2014 (Contd..2) 33
    Number of Products under Development by Companies, H1 2014 (Contd..3) 34


    Number of Products under Development by Companies, H1 2014 (Contd..4) 35
    Number of Products under Development by Companies, H1 2014 (Contd..5) 36
    Number of Products under Development by Companies, H1 2014 (Contd..6) 37
    Number of Products under Development by Companies, H1 2014 (Contd..7) 38
    Number of Products under Investigation by Universities/Institutes, H1 2014 40 & More.
    Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=279987.
    List of Figures
    Number of Products under Development for Psoriasis, H1 2014 28
    Number of Products under Development for Psoriasis - Comparative Analysis, H1 2014 29
    Number of Products under Development by Companies, H1 2014 30
    Number of Products under Investigation by Universities/Institutes, H1 2014 39
    Comparative Analysis by Late Stage Development, H1 2014 41
    Comparative Analysis by Clinical Stage Development, H1 2014 42
    Comparative Analysis by Early Stage Products, H1 2014 43
    Assessment by Monotherapy Products, H1 2014 166
    Number of Products by Top 10 Target, H1 2014 168
    Number of Products by Stage and Top 10 Target, H1 2014 169
    Number of Products by Top 10 Mechanism of Action, H1 2014 176
    Number of Products by Stage and Top 10 Mechanism of Action, H1 2014 177
    Number of Products by Top 10 Route of Administration, H1 2014 184
    Number of Products by Stage and Top 10 Route of Administration, H1 2014 185
    Number of Products by Top 10 Molecule Type, H1 2014 187
    Number of Products by Stage and Top 10 Molecule Type, H1 2014 188
    Inquiry Before Buying @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=279987
    Explore Report on Pharmaceuticals Market.
    Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Psoriasis - Pipeline Review, H1 2014” report OR for any other market research and intelligence needs you may have for your business.

    What do you think of this story?

    Select one of the options below. Your feedback will help tell CNN producers what to do with this iReport. If you'd like, you can explain your choice in the comments below.
    Be and editor! Choose an option below:
      Awesome! Put this on TV! Almost! Needs work. This submission violates iReport's community guidelines.

    Comments

    Log in to comment

    iReport welcomes a lively discussion, so comments on iReports are not pre-screened before they post. See the iReport community guidelines for details about content that is not welcome on iReport.

    Add your Story Add your Story